🔗 Share this article

Treasury head Reeves has stated she is planning "targeted measures to tackle household expense pressures" in the forthcoming Budget.

In comments to the BBC, she stated that lowering inflation is a joint duty of both the administration and the Bank of England.

The UK's inflation rate is projected to be the highest among the G7 advanced economies this calendar year and the following year.

Potential Energy Cost Interventions

Sources suggest the government could intervene to lower utility costs, for example by cutting the present 5% level of VAT applied on energy.

A further option is to reduce some of the policy costs presently included in household expenses.

Fiscal Limitations and Analyst Predictions

The government will obtain the latest draft from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much scope there is for such actions.

The expectation from the majority of analysts is that the Chancellor will have to introduce tax rises or expenditure reductions in order to adhere to her voluntary debt limits.

Previously on the same day, analysis showed there was a twenty-two billion pound gap for the Treasury chief to address, which is at the lower end of expectations.

"There's a collective responsibility between the central bank and the government to continue tackling some of the causes of inflation," the Chancellor told the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Issues

While a great deal of the attention has been on likely tax rises, the chancellor said the most recent information from the OBR had not changed her commitment to campaign commitments not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with growing international and trade issues for the Budget tax moves, likely to be targeted on those "with the broadest shoulders."

International Economic Disputes

Commenting on apprehensions about the United Kingdom's economic relations with the Asian nation she said: "Our national security invariably take priority."

Recent declaration by China to strengthen trade restrictions on critical minerals and other materials that are essential for advanced tech production led US President the US President to propose an extra 100% import tax on goods from the Asian country, raising the risk of an all-out trade war between the two global powers.

The US Treasury Secretary labeled the Chinese move "commercial pressure" and "a international production power grab."

Asked about accepting the American proposal to join its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "damaging for the international commerce and generates additional challenges."

"In my view there are sectors where we need to confront Chinese policies, but there are also important opportunities to export to Chinese markets, including banking sector and other areas of the economic system. We've got to get that equilibrium appropriate."

The chancellor also confirmed she was cooperating with international partners "regarding our own critical minerals strategy, so that we are less reliant."

NHS Medicine Costs and Investment

Reeves also acknowledged that the price the National Health Service pays for drugs could go up as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.

Some of the biggest global drug companies have said in recent statements that they are either halting or abandoning projects in the United Kingdom, with some attributing the modest returns they are receiving.

Last month, the Science Minister said the price the NHS pays for medicines would have to go up to halt businesses and drug research funding departing from the UK.

Reeves informed the BBC: "We have seen because of the cost structure, that clinical trials, recent pharmaceuticals have not been available in the UK in the extent that they are in other European countries."

"We want to guarantee that individuals receiving treatment from the NHS are able to access the best essential medicines in the globe. And so we are reviewing all of that, and... seeking to secure more investment into Britain."